AA
TMO icon

Altrafin AG’s Thermo Fisher Scientific TMO Stock Holding History

Altrafin AG’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-900
Closed -$442K – 56
2026
Q1 		$442K Sell
900
-713
-44% -$387K 0.15% 46
2025
Q4 		$934K Buy
1,613
+713
+79% +$403K 0.3% 33
2025
Q3 		$437K Hold
900
– – 0.14% 43
2025
Q2 		$365K Sell
900
-100
-10% -$41.8K 0.12% 46
2025
Q1 		$498K Sell
1,000
-2,160
-68% -$1.17M 0.19% 39
2024
Q4 		$1.64M Sell
3,160
-340
-10% -$187K 0.57% 34
2024
Q3 		$2.16M Buy
3,500
+500
+17% +$296K 0.78% 31
2024
Q2 		$1.66M Hold
3,000
– – 0.61% 34
2024
Q1 		$1.74M Buy
3,000
+500
+20% +$281K 0.63% 40
2023
Q4 		$1.33M Buy
2,500
+364
+17% +$176K 0.51% 42
2023
Q3 		$1.08M Hold
2,136
– – 0.47% 43
2023
Q2 		$1.11M Sell
2,136
-54
-2% -$29.1K 0.5% 44
2023
Q1 		$1.26M Hold
2,190
– – 0.62% 37
2022
Q4 		$1.21M Hold
2,190
– – 0.71% 36
2022
Q3 		$1.11M Buy
2,190
+76
+4% +$42.5K 0.67% 38
2022
Q2 		$1.15M Sell
2,114
-500
-19% -$275K 0.62% 41
2022
Q1 		$1.54M Buy
2,614
+49
+2% +$28.1K 0.61% 40
2021
Q4 		$1.71M Buy
+2,565
New +$1.6M 0.62% 45

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Altrafin AG's TMO Position: Q2 2026 in Review

Altrafin AG sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 900 shares — an estimated $442K sold.

Altrafin AG first reported a position in TMO in Q4 2021 and held it in 18 quarters. The position peaked at $2.16M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Altrafin AG reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Altrafin AG sold 900 Thermo Fisher Scientific shares in Q2 2026, an estimated $442K.
  • Altrafin AG first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 18 quarters.
  • Altrafin AG's Thermo Fisher Scientific position peaked at $2.16M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.